Omada Health (NASDAQ:OMDA) Share Price Crosses Below Two Hundred Day Moving Average on Insider Selling

Key Points

• Omada Health shares fell below their 200-day moving average of $17.74, trading as low as $14.75 and last at $15.09. CEO Sean Duffy sold 12,944 shares for about $249,000, reducing his stake by 3.27%.
• Omada reported Q3 revenue of $91.3 million, up 34% year over year, and EPS of $0.10 versus the $0.02 consensus estimate; membership grew 36% to 1.1 million, and the company raised its 2026 outlook.
• Analyst views remain broadly positive, with a MarketBeat “Moderate Buy” consensus and average price target of $26.33, though some firms recently lowered targets or ratings.

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Friday following insider selling activity. The stock has a 200-day moving average of $17.74 and traded as low as $14.75. Omada Health shares last traded at $15.09, with a volume of 4,709,304 shares trading hands.

Specifically, CEO Sean Duffy sold 12,944 shares of the firm's stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $19.22, for a total value of $248,783.68. Following the transaction, the chief executive officer directly owned 382,594 shares of the company's stock, valued at $7,353,456.68. This trade represents a 3.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on OMDA shares. JPMorgan Chase & Co. raised their price objective on Omada Health from $26.00 to $30.00 and gave the stock an "overweight" rating in a research report on Friday, August 14th. Robert W. Baird upped their price target on Omada Health from $15.00 to $25.00 and gave the company a "neutral" rating in a research report on Wednesday, August 12th. Citigroup restated an "outperform" rating on shares of Omada Health in a research report on Friday, August 14th. Wall Street Zen upgraded shares of Omada Health from a "hold" rating to a "buy" rating in a research report on Sunday, October 11th. Finally, Barclays decreased their price target on shares of Omada Health from $24.00 to $22.00 and set an "overweight" rating for the company in a research note on Friday. Eleven research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $26.33.

Omada Health News Summary

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Omada reported Q3 revenue of $91 million, up 34% year over year, and total members grew 36% to a record 1.1 million. Net income was $7 million versus a year-ago loss, while adjusted EBITDA increased to $12 million. The company also raised its full-year 2026 financial outlook. Omada Health Reports Third Quarter 2026 Results
• Positive Sentiment: Quarterly revenue exceeded FactSet’s estimate, and reported earnings also topped consensus estimates, providing evidence of stronger-than-expected operating performance. Earnings Flash: Q3 Revenue
• Neutral Sentiment: Unusual options activity was reported after Omada’s earnings, signaling heightened trading interest but not indicating a clear direction for the stock. Unusual Options Volume Report
• Negative Sentiment: Several analysts took a more cautious stance: Wells Fargo cut its price target to $19 and maintained an “equal weight” rating, while Zacks Research downgraded OMDA from “strong buy” to “hold.” Wells Fargo analyst actions Zacks Research analyst action
• Negative Sentiment: Barclays also lowered its target from $24 to $22, although it retained an “overweight” rating. Barclays analyst action

Omada Health Stock Performance

The company has a market capitalization of $923.81 million, a PE ratio of 71.86 and a beta of 2.13. The stock has a fifty day moving average of $20.14 and a 200 day moving average of $17.74.

Omada Health (NASDAQ:OMDA - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.08. The firm had revenue of $91.31 million for the quarter. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. As a group, equities analysts predict that Omada Health, Inc. will post 0.09 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. China Universal Asset Management Co. Ltd. acquired a new position in Omada Health during the 3rd quarter valued at approximately $70,000. Sterling Capital Management LLC boosted its stake in shares of Omada Health by 1,161.6% in the third quarter. Sterling Capital Management LLC now owns 1,577 shares of the company's stock valued at $33,000 after purchasing an additional 1,452 shares during the period. Robeco Institutional Asset Management B.V. purchased a new stake in shares of Omada Health during the third quarter worth approximately $1,100,000. Counterpoint Mutual Funds LLC acquired a new stake in shares of Omada Health during the 3rd quarter worth about $595,000. Finally, State of Alaska Department of Revenue purchased a new stake in Omada Health in the third quarter valued at $59,000.

About Omada Health

Omada Health, Inc NASDAQ: OMDA is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.

The company's offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada's technology platform.

Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.